Active Infection & Immunity Cells, Biochemistry & Physiology

Defining how cell wall changes during infection affect Cryptococcus neoformans virulence

In plain English

AI plain-English summary

Every year, over 112,000 people living with HIV die from cryptococcal meningitis because existing antifungal drugs cannot clear the infection. The pathogen, *Cryptococcus neoformans*, hides behind a rigid inner cell wall that supports its outer sugar capsule, but researchers have largely ignored how that wall changes during a real infection. Most studies have only examined the capsule in standard lab conditions, missing the dynamic shifts the cell wall undergoes inside a patient. This project will map those infection-specific changes for the first time. Because human cells lack a cell wall entirely, any vulnerability found in the fungal wall is a clean target for new drugs. If the research succeeds, it could reveal a molecular weak point that pharmaceutical companies can exploit to design antifungals that work where current treatments fail. This is fundamental science with a direct path to application: understanding the wall’s shape-shifting behaviour is a prerequisite for building drugs that stop it.

View original technical description
Cryptococcal meningitis is a disease caused by the pathogen Cryptococcus neoformans (C. neoformans), which targets patients with weakened immunity, such as those with cancer, organ transplant and HIV/AIDS. It kills over 112,000 people living with HIV each year as antifungal drug treatments are currently inadequate. To develop more effective drugs, we need a better understanding of how Cryptococcus causes this terrible disease. The C. neoformans external surface consists of a bi-layered outer shield made of sugars. The outermost layer is gelatinous and called the capsule. The inner layer, the cell wall, is rigid and confers structure and physical strength. Previous research has focussed on the outermost layer, as it protects Cryptococcus from the immune system. However, my research shows the inner cell wall layer, on which the capsule depends, undergoes dynamic changes during infection that are not see in standard laboratory conditions. This project aims to characterise cell wall changes occurring during Cryptococcus infection, and how these changes influence disease progression. As the cell wall is absent in human cells, this project will provide crucial new information that will be required for future antifungal drug development.

View the original record at the funder ↗

Researchers

Liliane Mukaremera (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Elucidating the impact of chitin and chitin-like structures on C. neoformans virulence
Roles of Cryptococcus cell wall dynamics during infection and antifungal drug resistance
Role and Control of the Functional Specialisation of Microglia during Fungal Meningitis
Interrogating Host-Pathogen Interactions during Fungal Meningitis
Dynamics of brain invasion by the pathogenic fungus Cryptococcus neoformans

Original classification

Wellcome Accelerator Awards

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.